As of 2025-03-19, the EV/EBITDA ratio of Prestige Consumer Healthcare Inc (PBH) is 14.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PBH's latest enterprise value is 5,103.47 mil USD. PBH's TTM EBITDA according to its financial statements is 360.45 mil USD. Dividing these 2 quantities gives us the above PBH EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 19.8x | 16.7x |
| Forward P/E multiples | 14.1x - 19.1x | 16.8x |
| Fair Price | 75.20 - 124.97 | 101.52 |
| Upside | -10.4% - 48.9% | 21.0% |
| Date | EV/EBITDA |
| 2025-03-04 | 14.20 |
| 2025-03-03 | 14.34 |
| 2025-02-28 | 14.27 |
| 2025-02-27 | 14.13 |
| 2025-02-26 | 14.46 |
| 2025-02-25 | 14.63 |
| 2025-02-24 | 14.32 |
| 2025-02-21 | 14.26 |
| 2025-02-20 | 14.28 |
| 2025-02-19 | 14.29 |
| 2025-02-18 | 14.33 |
| 2025-02-14 | 14.44 |
| 2025-02-13 | 14.40 |
| 2025-02-12 | 14.20 |
| 2025-02-11 | 14.44 |
| 2025-02-10 | 14.61 |
| 2025-02-07 | 14.58 |
| 2025-02-06 | 14.63 |
| 2025-02-05 | 13.08 |
| 2025-02-04 | 13.04 |
| 2025-02-03 | 12.98 |
| 2025-01-31 | 13.18 |
| 2025-01-30 | 13.40 |
| 2025-01-29 | 13.45 |
| 2025-01-28 | 13.53 |
| 2025-01-27 | 13.51 |
| 2025-01-24 | 13.16 |
| 2025-01-23 | 13.17 |
| 2025-01-22 | 13.26 |
| 2025-01-21 | 13.52 |
| 2025-01-17 | 13.42 |
| 2025-01-16 | 13.38 |
| 2025-01-15 | 13.24 |
| 2025-01-14 | 13.04 |
| 2025-01-13 | 12.88 |
| 2025-01-10 | 12.80 |
| 2025-01-08 | 12.85 |
| 2025-01-07 | 12.77 |
| 2025-01-06 | 12.87 |
| 2025-01-03 | 13.19 |
| 2025-01-02 | 13.31 |
| 2024-12-31 | 13.36 |
| 2024-12-30 | 13.26 |
| 2024-12-27 | 13.41 |
| 2024-12-26 | 13.51 |
| 2024-12-24 | 13.45 |
| 2024-12-23 | 13.42 |
| 2024-12-20 | 13.44 |
| 2024-12-19 | 13.44 |
| 2024-12-18 | 13.45 |